Author:
van Mens Leonieke J J,Turina Maureen C,van de Sande Marleen G H,Nurmohamed Mike T,van Kuijk Arno W R,Baeten Dominique L P
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference21 articles.
1. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial;Lancet,2013
2. Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-c;Ann Rheum Dis,2014
3. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor;Ann Rheum Dis,2014
4. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis;N Engl J Med,2015
5. Group for research and assessment of psoriasis and psoriatic arthritis: Treatment recommendations for psoriatic arthritis 2015;Arthritis Rheumatol,2016
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献